亚太药业: 关于亚药转债即将到期及停止交易的第五次提示性公告

Core Viewpoint - The announcement serves as a reminder for the upcoming maturity and cessation of trading of the "YaYao Convertible Bonds" (亚药转债), emphasizing the importance for bondholders to convert their bonds into company shares before the deadline [1][2][5]. Group 1: Convertible Bond Issuance Details - The company issued 9.65 million convertible bonds at a face value of 100 RMB each, totaling 965 million RMB, which were listed on April 24, 2019 [1]. - The conversion price for the bonds is currently set at 3.00 RMB per share [5]. Group 2: Redemption and Trading Cessation - The bonds will be redeemed at 115% of their face value, amounting to 115 RMB per bond, including the last interest payment, within five trading days after maturity [2]. - The last trading day for the bonds is set for March 28, 2025, with trading ceasing on March 31, 2025 [5]. Group 3: Additional Information - The company will disclose further details regarding the maturity redemption and delisting of the bonds on designated information platforms [5].